LISATA THERAPEUTICS, INC. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share
LISATA THERAPEUTICS, INC. (LSTA) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share of $0.00 per share for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare · last filed 2018-11-08
- LISATA THERAPEUTICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2018-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2018-03-31 was $0.00.
- LISATA THERAPEUTICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2017-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2014 was $0.00.
- LISATA THERAPEUTICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2013 was $0.00.
- LISATA THERAPEUTICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2012 was -$1.30.
- LISATA THERAPEUTICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2011 was -$0.15.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 3 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 6 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 9 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 12 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | ||||||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | ||||||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | |||||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 | $4.30 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | $4.56 10-Q · filed 2018-08-09 | $4.38 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | -$0.33 10-Q · filed 2018-05-10 | |||||||
| 2016-09-30 | -$0.13 10-Q · filed 2017-11-09 | -$0.22 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | -$0.03 10-Q · filed 2017-08-10 | -$0.08 10-Q · filed 2017-08-10 | ||||||
| 2014-12-31 | $0.00 10-K · filed 2015-03-02 | |||||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-02 | |||||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | ||||||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-08 | $0.00 10-Q · filed 2013-08-08 | ||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | |||||||
| 2012-12-31 | -$1.30 10-K · filed 2015-03-02 | -$0.13 10-K · filed 2013-03-11 | ||||||
| 2012-09-30 | $0.01 10-Q · filed 2013-11-07 | $0.00 10-Q · filed 2012-11-13 | -$1.12 10-Q · filed 2013-11-07 | -$0.11 10-Q · filed 2012-11-13 | ||||
| 2012-06-30 | -$0.99 10-Q · filed 2013-08-08 | -$0.10 10-Q · filed 2012-08-14 | -$1.20 10-Q · filed 2013-08-08 | -$0.12 10-Q · filed 2012-08-14 | ||||
| 2012-03-31 | -$0.01 10-Q · filed 2013-05-09 | -$0.02 10-Q · filed 2012-05-11 | ||||||
| 2011-12-31 | -$0.15 10-K · filed 2013-03-11 | |||||||
| 2011-09-30 | -$0.01 10-Q · filed 2012-11-13 | -$0.02 10-Q · filed 2012-11-13 | ||||||
| 2011-06-30 | -$0.01 10-Q · filed 2012-08-14 | -$0.01 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | -$0.01 10-Q · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |